· 自动抓取 · 最新研究 · 1 分钟阅读
CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas
Leukemia, Published online: 26 June 2026; doi:10.1038/s41375-026-03018-wCircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas
Leukemia, Published online: 26 June 2026; doi:10.1038/s41375-026-03018-wCircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas
本文自动抓取自 Leukemia，原文链接：CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas
原文发布日期：2026-06-26
